 <a id="main-content" tabindex="-1"></a>  version="1.0" encoding="UTF-8"?             

 

 version="1.0" encoding="UTF-8"?             

 

 

      Sub-navigation   Navigation links - Current: Sub-navigation     

- [ Published Studies by MeVac ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/published-studies)
- [ For Collaborators ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/collaborators)
- [ General Information about Vaccines ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/general)
- [ Participation in Research ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/participation)
 


 



 

- [ Published Studies by MeVac ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/published-studies)
- [ For Collaborators ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/collaborators)
- [ General Information about Vaccines ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/general)
- [ Participation in Research ](/en/research-and-education/scientific-research/meilahti-vaccine-research-center-mevac/participation)
 


 

 

  #  Participation in Research 

Participation is always voluntary and can be discontinued at any time. By joining in a research project you contribute to the development of health-promoting interventions – and broaden the range of your vaccine protection for free.

Before the study, you will be thoroughly briefed on its course, your suitability will be assessed, and your written consent to participate will be requested. Usually no payment is offered. As participant, you will receive either the investigational vaccine, a placebo, or a comparator vaccine already in common use. Most studies involve clinic visits, laboratory sampling, and follow-ups by phone or smart applications.

Throughout the study, a detailed research plan approved by the drug regulatory authority and ethics committee is meticulously followed.

 



 

##  Contact Us 

Meilahti Vaccine Research Center (MeVac)   
<vaccine@hus.fi>  
tel. +358 50 311 6365

**Address:**  
Biomedicum Helsinki 1  
Haartmaninkatu 8  
00290 Helsinki

 



 

  

 

  Updated: 19.08.2025

   Print this page